Hofmeister Robert

Track

Insider profile

Hofmeister Robert's trades of TCR2 Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
133.02
Quantity 28,897 -49.2%
Value US$4,884,571
Transaction date
Planned sale
Price
164.21
Quantity 38,478 -10.5%
Value US$1,241,721
Transaction date
Planned sale
Price
472.10
Quantity 43,110 -37.6%
Value US$226,155
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-11-13 2020-11-12
PlS Planned sale
28,897 -49.2%
133.02
US$4,884,571 		28,897 -49.2% 133.02 US$4,884,571
2020-11-13 2020-11-12
PlS Planned sale
38,478 -10.5%
164.21
US$1,241,721 		38,478 -10.5% 164.21 US$1,241,721
2020-11-02 2020-10-29
PlS Planned sale
43,110 -37.6%
472.10
US$226,155 		43,110 -37.6% 472.10 US$226,155